US 10179131
Hepatitis B antiviral agents
granted A61KA61K31/505A61K31/506
Quick answer
US patent 10179131 (Hepatitis B antiviral agents) held by Enanta Pharmaceuticals, Inc. expires Mon Jan 10 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Enanta Pharmaceuticals, Inc.
- Grant date
- Tue Jan 15 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 10 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 15
- CPC classes
- A61K, A61K31/505, A61K31/506, A61K31/5377, A61K31/5386